7 research outputs found
The Physics of Cluster Mergers
Clusters of galaxies generally form by the gravitational merger of smaller
clusters and groups. Major cluster mergers are the most energetic events in the
Universe since the Big Bang. Some of the basic physical properties of mergers
will be discussed, with an emphasis on simple analytic arguments rather than
numerical simulations. Semi-analytic estimates of merger rates are reviewed,
and a simple treatment of the kinematics of binary mergers is given. Mergers
drive shocks into the intracluster medium, and these shocks heat the gas and
should also accelerate nonthermal relativistic particles. X-ray observations of
shocks can be used to determine the geometry and kinematics of the merger. Many
clusters contain cooling flow cores; the hydrodynamical interactions of these
cores with the hotter, less dense gas during mergers are discussed. As a result
of particle acceleration in shocks, clusters of galaxies should contain very
large populations of relativistic electrons and ions. Electrons with Lorentz
factors gamma~300 (energies E = gamma m_e c^2 ~ 150 MeV) are expected to be
particularly common. Observations and models for the radio, extreme
ultraviolet, hard X-ray, and gamma-ray emission from nonthermal particles
accelerated in these mergers are described.Comment: 38 pages with 9 embedded Postscript figures. To appear in Merging
Processes in Clusters of Galaxies, edited by L. Feretti, I. M. Gioia, and G.
Giovannini (Dordrecht: Kluwer), in press (2001
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
Aims The aim of this study was to develop, validate, and illustrate an updated prediction model (SCORE2) to estimate 10-year fatal and non-fatal cardiovascular disease (CVD) risk in individuals without previous CVD or diabetes aged 40-69 years in Europe.Methods and results We derived risk prediction models using individual-participant data from 45 cohorts in 13 countries (677 684 individuals, 30 121 CVD events). We used sex-specific and competing risk-adjusted models, including age, smoking status, systolic blood pressure, and total- and HDL-cholesterol. We defined four risk regions in Europe according to country-specific CVD mortality, recalibrating models to each region using expected incidences and risk factor distributions. Region-specific incidence was estimated using CVD mortality and incidence data on 10 776 466 individuals. For external validation, we analysed data from 25 additional cohorts in 15 European countries (1 133 181 individuals, 43 492 CVD events). After applying the derived risk prediction models to external validation cohorts, C-indices ranged from 0.67 (0.65-0.68) to 0.81 (0.76-0.86). Predicted CVD risk varied several-fold across European regions. For example, the estimated 10-year CVD risk for a 50-year-old smoker, with a systolic blood pressure of 140 mmHg, total cholesterol of 5.5 mmol/L, and HDL-cholesterol of 1.3 mmol/L, ranged from 5.9% for men in low- risk countries to 14.0% for men in very high-risk countries, and from 4.2% for women in low-risk countries to 13.7% for women in very high-risk countries.Conclusion SCORE2-a new algorithm derived, calibrated, and validated to predict 10-year risk of first-onset CVD in European populations-enhances the identification of individuals at higher risk of developing CVD across Europe.Cardiolog
The effects of the Pro12Ala polymorphism of the peroxisome proliferator–activated receptor-2 gene on glucose/Insulin metabolism interact with prenatal exposure to famine
OBJECTIVE: An adverse fetal environment may permanently modify the effects of specific genes on glucose tolerance, insulin secretion, and insulin sensitivity. In the present study, we assessed a possible interaction of the peroxisome proliferator-activated receptor (PPAR)-gamma2 Pro12Ala polymorphism with prenatal exposure to famine on glucose and insulin metabolism.RESEARCH DESIGN AND METHODS: We measured plasma glucose and insulin concentrations after an oral glucose tolerance test and determined the PPAR-gamma2 genotype among 675 term singletons born around the time of the 1944-1945 Dutch famine. RESULTS: A significant interaction effect between exposure to famine during midgestation and the PPAR-gamma2 Pro12Ala polymorphism was found on the prevalence of impaired glucose tolerance and type 2 diabetes. The Ala allele of the PPAR-gamma2 gene was associated with a higher prevalence of impaired glucose tolerance and type 2 diabetes but only in participants who had been prenatally exposed to famine during midgestation. Similar interactions were found for area under the curve for insulin and insulin increment ratio, which were lower for Ala carriers exposed to famine during midgestation. CONCLUSIONS: The effects of the PPAR-gamma2 Pro12Ala polymorphism on glucose and insulin metabolism may be modified by prenatal exposure to famine during midgestation. This is possibly due to a combined deficit in insulin secretion, as conferred by pancreatic beta-cell maldevelopment and carrier type of the Ala allele in the PPAR-gamma2 gene